Aguiar, Pedro Nazareth <br/><br/>
Cost effectiveness of chemohormonal therapy in patients with metastatic hormone-sensitive and non-metastatic high-risk prostate cancer.  [electronic resource] 

 -  Einstein (Sao Paulo, Brazil)   
 - 349-354 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2317-6385 
<br/><br/><label>Standard No.: </label>10.1590/S1679-45082017GS4017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgen Receptor Antagonists--administration & dosage<br/>Antineoplastic Agents, Hormonal--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--economics<br/>Cost-Benefit Analysis<br/>Docetaxel<br/>Humans<br/>Male<br/>Prostatic Neoplasms--drug therapy<br/>Quality-Adjusted Life Years<br/>Taxoids--administration & dosage<br/>Treatment Outcome